FARA Supports Therapeutic Development Across the R & D Continuum

Therapeutic Development Across the R&D Continuum

FARA will bring significant resources and infrastructure to a therapeutic development program.  FARA is committed to helping cut preclinical and clinical development time to a minimum and getting products to market faster and at a lower cost.  Our collaborations and meetings with international partners give us global reach, with access to expertise, patients and clinicians around the world.

 To discuss one or more of the ways FARA can help, please contact:

Jennifer Farmer
Chief Executive Officer
This email address is being protected from spambots. You need JavaScript enabled to view it. 
(484) 879-6160

Additional Resources:

Clinical Trials in Children With Friedreich Ataxia